Stocks
Blueprint Medicines Corporation (BPMC) EBITDA margin US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | |||
| EBITDA margin, % | ? | 38.9% | -348.9% | -252.6% | -188.6% | 3.78% | -23.3% | |
| Changes by years, y/y, % | +574pp | -388pp | +96pp | +64pp | +192pp | |||
Blueprint Medicines Corporation. EBITDA margin, %
Blueprint Medicines Corporation. EBITDA margin, changes, pp
Blueprint Medicines Corporation (BPMC) EBITDA margin US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | LTM ? | |||
| EBITDA margin, % | ? | 113.6% | -21.3% | -26.0% | -18.5% | -27.5% | -23.3% | |
| Changes by years, y/y, % | +290pp | +178pp | +178pp | +125pp | -141pp | |||
| Changes by quarters, q/q, % | +258pp | -135pp | -5pp | +8pp | -9pp | |||
